Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine. | Aplastic Anemia and MDS International Foundation
  1. Education
  2. Recent Research

Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.

Journal Title: 
Ann Hematol
Author(s): 
Abáigar M, Ramos F, Benito R, Díez-Campelo M, Sánchez-Del-Real J, Hermosín L, Rodríguez JN, Aguilar C, Recio I, Alonso JM, de Las Heras N, Megido M, Fuertes M, Del Cañizo MC, Hernández-Rivas JM.
Primary Author: 
Abáigar M
Original Publication Date: 
Thursday, June 6, 2013

No abstract available.

Bone Marrow Diseases: 
myelodysplastic syndromes (MDS)